Vitrafy Life Sciences公布中期税后亏损710万澳元

投资观察
Feb 04

2月4日(路透社)—— Vitrafy Life Sciences Ltd(ASX: VFY)发布中期财报,公司税后亏损达710万澳元。该生物科技公司持续面临研发投入与市场拓展的双重压力,业绩表现低于市场预期。

更多公司相关报道请关注VFY.AX。数据来源时间:2026年2月4日01:37:17 GMT

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10